| abstract |
BACKGROUND OF THE INVENTION The present invention relates to a novel method for preventing or reducing post-ischemic heart injury, in particular myocardial infarction, or improving the functional healing of cardiac myocardial ischemia, wherein a human or non-human mammal in need of such treatment is a glucose uptake inhibitor such as dioxin. An effective non-toxic amount of [4- {2- [N-methyl-N- (2-pyridyl) amino] ethoxy} benzyl] -2,4-dioxothiazolidine is provided. SHE |